Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease / Fiorino, G; Ruiz-Aguello, Mb; Maguregui, A; Nagore, D; Radice, S; Gilardi, D; Correale, C; Allocca, M; Furfaro, F; Alfieri, M; Martinez, A; Danese, S. - In: JOURNAL OF CROHN'S AND COLITIS. - ISSN 1873-9946. - 11(2017), pp. S403-S404.
Titolo: | Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease |
Autori: | |
Data di pubblicazione: | 2017 |
Rivista: | |
Handle: | http://hdl.handle.net/11699/12814 |
Appare nelle tipologie: | 1.5 Abstract in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease.pdf | Versione Editoriale (PDF) | Copyright dell'editore | Administrator Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.